ketanserin has been researched along with dexfenfluramine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Archer, SL; Michelakis, ED; Nelson, DP; Reeve, HL; Tolarova, S; Weir, EK | 1 |
Buck, A; Burger, C; Dörig, N; Hasler, F; Quednow, BB; Rentsch, KM; Schubiger, PA; Treyer, V; Vollenweider, FX; Westera, G; Wyss, MT | 1 |
1 trial(s) available for ketanserin and dexfenfluramine
Article | Year |
---|---|
Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.
Topics: Adult; Brain; Dexfenfluramine; Double-Blind Method; Fluorine Radioisotopes; Humans; Ketanserin; Male; Positron-Emission Tomography; Serotonin; Serotonin Receptor Agonists; Young Adult | 2012 |
4 other study(ies) available for ketanserin and dexfenfluramine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Dexfenfluramine elevates systemic blood pressure by inhibiting potassium currents in vascular smooth muscle cells.
Topics: 4-Aminopyridine; Animals; Arteries; Blood Pressure; Calcium; Calcium Channels; Dexfenfluramine; Electrophysiology; Enzyme Inhibitors; In Vitro Techniques; Ion Channel Gating; Ketanserin; Male; Membrane Potentials; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Patch-Clamp Techniques; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 1999 |